Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cosmos Health Inc. to acquire Cana Laboratories

Announced Jul 6, 2023 · Closed Jul 6, 2023 · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Cosmos Health Inc. (COSM)
Target
Cana Laboratories
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Jul 6, 2023

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Sources
  • 8-K (EX-99.1) · Jul 6, 2023

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.